Latest On MiMedx Group, Inc (MDXG):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-06 11:18 EST | News | MiMedx's Post-Q1 2023 Surge Could Result In Profit-Taking | N/A |  |
| 2023-05-03 19:46 EST | News | MiMedx surges ~30% after Q1 revenue growth, cost controls drive down net loss | N/A | |
| 2023-05-03 06:37 EST | News | MiMedx Group, Inc. (MDXG) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-02 18:35 EST | News | MiMedx Group GAAP EPS of -$0.06 beats by $0.03, revenue of $71.68M beats by $7.53M | N/A | |
| 2023-05-01 18:02 EST | News | MiMedx Group Q1 2023 Earnings Preview | N/A | |
| 2023-03-24 05:26 EST | News | MiMedx CFO Carlson to leave company | N/A | |
| 2023-03-01 05:59 EST | News | MiMedx Group GAAP EPS of -$0.02, revenue of $74.38M | N/A | |
| 2023-03-01 05:59 EST | News | MiMedx Group, Inc. (MDXG) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-28 00:24 EST | News | MiMedx Group Q4 2022 Earnings Preview | N/A | |
| 2023-01-30 10:01 EST | News | MiMedx appoints deal maker Joseph Capper as new CEO | N/A | |
| 2023-01-10 18:33 EST | News | MIMEDX continues to see Q4 net sales in the range of $73M to $76M | N/A | |
| 2023-01-09 12:05 EST | News | MIMEDX continues to see Q4 net sales in the ranges of $73M to $76M | N/A | |
| 2023-01-05 04:25 EST | News | MiMedx announces commercial launch of EPIFIX product in Japan with distribution deal | N/A | |
| 2022-11-03 04:07 EST | News | MiMedx Group GAAP EPS of -$0.09 in-line, revenue of $67.69M beats by $0.96M | N/A | |
| 2022-11-03 04:07 EST | News | MiMedx Group, Inc. 2022 Q3 - Results - Earnings Call Presentation | N/A | |
| 2022-11-03 04:07 EST | News | MiMedx Group, Inc. (MDXG) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-01 20:49 EST | News | MiMedx Group Q3 2022 Earnings Preview | N/A | |
| 2022-09-13 05:10 EST | News | MiMedx gets Japanese reimbursement approval for its tissue allograft EPIFIX | N/A | |
| 2022-09-06 20:37 EST | News | MiMedx Group expects AWC full-year sales in low end of 11%-14% growth range | N/A | |
| 2022-08-03 15:56 EST | News | MiMedx Group, Inc.'s (MDXG) CEO Tim Wright on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-03 01:47 EST | News | MiMedx Group GAAP EPS of -$0.11 misses by $0.04, revenue of $66.88M beats by $1.81M | N/A | |
| 2022-08-01 20:44 EST | News | MiMedx Group Q2 2022 Earnings Preview | N/A | |
| 2022-06-15 20:40 EST | News | MiMedx contracts with Nordic Bioscience to support knee osteoarthritis therapy trials | N/A | |
| 2022-05-31 16:59 EST | News | MiMedx wins $4.6M contract from US DoD for wound, burn care solution | N/A | |
| 2022-05-04 19:58 EST | News | MiMedx Group, Inc. (MDXG) CEO Tim Wright on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-04 02:02 EST | News | MiMedx Group GAAP EPS of -$0.11 misses by $0.01, revenue of $58.89M beats by $4.79M | N/A | |
| 2022-05-03 07:47 EST | News | MiMedx Group Q1 2022 Earnings Preview | N/A | |
| 2022-03-28 10:49 EST | News | MiMedx Group (MDXG) Presents at the Canaccord Genuity Musculoskeletal Conference - Slideshow | N/A | |
| 2022-03-01 01:21 EST | News | MiMedx Group GAAP EPS of $0.01 beats by $0.04, revenue of $67.29M beats by $3.6M | N/A | |
| 2022-03-01 01:21 EST | News | MiMedx Group, Inc. (MDXG) CEO Tim Wright on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-28 05:34 EST | News | MiMedx Group Q4 2021 Earnings Preview | N/A | |
| 2022-01-28 18:51 EST | News | MiMedx rises as federal court dismisses securities class action lawsuit against company | N/A | |
| 2022-01-11 06:38 EST | News | MiMedx sees 2022 annual revenue growth of 11%-14%, outlines key strategic milestones for 2022 | N/A | |
| 2021-12-08 00:17 EST | News | MiMedx raises sales guidance ahead of investor event | N/A | |
| 2021-11-04 01:45 EST | News | MiMedx up 15% as net loss narrows in Q3 and beats Street expectations | N/A | |
| 2021-11-04 01:45 EST | News | MiMedx Group, Inc. (MDXG) CEO Tim Wright on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-03 05:58 EST | News | MiMedx Group EPS beats by $0.05, beats on revenue | N/A | |
| 2021-11-02 10:13 EST | News | MiMedx Group Q3 2021 Earnings Preview | N/A | |
| 2021-10-12 18:41 EST | News | Warning: MDXG is at high risk of performing badly | N/A | |
| 2021-10-07 01:59 EST | News | MDXG is at high risk of performing badly | N/A | |
| 2021-09-27 10:20 EST | News | Warning: MDXG has been downgraded to Very Bearish | N/A | |
| 2021-09-25 16:06 EST | News | BELLUS Health, Akoya Biosciences lead weekly healthcare gainers; Protagonist trail | N/A | |
| 2021-09-22 17:52 EST | News | MiMedx plunges after setback for two late-stage musculoskeletal clinical trials | N/A | |
| 2021-09-22 17:50 EST | News | Warning: MDXG has been downgraded to Very Bearish. | N/A | |
| 2021-09-22 17:50 EST | News | BELLUS Health, Akoya Biosciences lead weakly healthcare gainers; Protagonist trail | N/A | |
| 2021-08-27 22:13 EST | News | MiMedx Group files registration statement on Form S-3 | N/A | |
| 2021-08-04 21:40 EST | News | MiMedx Group, Inc. (MDXG) CEO Tim Wright on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-04 00:54 EST | News | MiMedx Group EPS beats by $0.04, beats on revenue | N/A | |
| 2021-07-22 16:23 EST | News | Mimedx's Epifix secures regulatory approval in Japan | N/A | |
| 2021-07-22 16:19 EST | News | MiMedx joins Russell 3000 and 2000 Indexes | N/A | |
About MiMedx Group, Inc (MDXG):
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, pressure ulcers, and burns; AmnioFix, a semi-permeable protective barrier membrane product for the treatment of wounds related to surgical procedures; EpiCord and AmnioCord that are dehydrated human umbilical cord allografts intended for homologous applications; and AmnioFill that consists of particles of connective tissue matrix derived from placental disc and placental membranes. The company's products have applications primarily in the areas of wound care, burn, surgical, and non-operative sports medicine sectors of healthcare. It also sells allografts for dental applications on an original equipment manufacturer basis. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. is headquartered in Marietta, Georgia.
General
- Name MiMedx Group, Inc
- Symbol MDXG
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Devices
- Full Time Employees 735
- Last Split Factor3235:10000
- Last Split Date2008-04-02
- Fiscal Year EndDecember
- IPO Date2007-08-22
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.mimedx.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 3.94
- Price/Book (Most Recent Quarter) 85.59
- Enterprise Value Revenue 3.86
- Enterprise Value EBITDA 117.93
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.05
- Next Year EPS Estimate $0.22
- Profit Margin -20%
- Operating Margin -18%
- Return on Assets -15%
- Return on Equity -78%
- Revenue 248.23 million
- Earnings Per Share $0.31
- Revenue Per Share $2.29
- Gross Profit 208.9 million
- Quarterly Earnings Growth -10.3%
View More
Highlights
- Market Capitalization 980.21 million
- EBITDA 7.71 million
- PE Ratio 16.3
- PEG Ratio 2.97
- Analyst Target Price $16
- Book Value Per Share $0.12
View More
Share Statistics
- Shares Outstanding 111.04 million
- Shares Float 74.07 million
- % Held by Insiders 637%
- % Held by Institutions 12.1%
- Shares Short 7.57 million
- Shares Short Prior Month 7.54 million
- Short Ratio 15.29
- Short % of Float 9%
- Short % of Shares Outstanding 7%
View More
Technicals
- Beta 1.66
- 52 Week High $11.44
- 52 Week Low $2.95
- 50 Day Moving Average 9.84
- 200 Day Moving Average 7.82
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
MiMedx Group, Inc (MDXG) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
MiMedx Group, Inc (MDXG) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-08 | $68.55 million | -$0.17 | -$0.05 | -240% |
| 2020-09-30 | 2020-11-04 | $N/A | -$0.48 | ||
| 2020-06-30 | 2020-07-06 | $53.65 million | -$0.04 | ||
| 2020-03-31 | 2020-06-30 | $61.74 million | -$0.08 | $0.00 | |
| 2019-12-31 | 2020-03-31 | $76.4 million | -$0.04 | $0.11 | -140.73% |
| 2019-09-30 | 2019-12-31 | $88.86 million | -$0.07 | ||
| 2019-06-30 | 2019-09-30 | $67.44 million | $0.11 | ||
| 2019-03-31 | 2019-06-30 | $66.56 million | -$0.16 | ||
| 2018-12-31 | 2019-03-31 | $N/A | -$0.12 | $0.00 | |
| 2018-09-30 | 2018-12-31 | -$0.33 | $0.00 | ||
| 2018-06-30 | 2018-07-26 | $0.02 | |||
| 2018-03-31 | 2018-04-26 | $0.04 | |||
| 2017-12-31 | 2017-12-31 | $0.38 | $0.11 | 245.45% | |
| 2017-09-30 | 2017-10-26 | $84.57 million | $0.15 | $0.05 | 200% |
| 2017-06-30 | 2017-07-26 | $76.41 million | $0.07 | $0.04 | 83.25% |
| 2017-03-31 | 2017-04-28 | $72.61 million | $0.04 | $0.04 | 5.26% |
| 2016-12-31 | 2017-02-23 | $69.88 million | $0.05 | $0.04 | 27.55% |
| 2016-09-30 | 2016-10-27 | $64.43 million | $0.03 | $0.02 | 42.18% |
| 2016-06-30 | 2016-07-26 | $57.34 million | $0.02 | $0.03 | -30.31% |
| 2016-03-31 | 2016-04-26 | $53.37 million | $0.01 | $0.04 | -76.19% |
| 2015-12-31 | 2016-02-23 | $51.84 million | $0.12 | $0.06 | 100% |
| 2015-09-30 | 2015-10-29 | $49.02 million | $0.06 | $0.06 | 0% |
| 2015-06-30 | 2015-07-30 | $45.68 million | $0.05 | $0.05 | 0% |
| 2015-03-31 | 2015-04-27 | $40.77 million | $0.04 | $0.03 | 33.33% |
| 2014-12-31 | 2015-02-26 | $39.57 million | $0.03 | $0.03 | 0% |
| 2014-09-30 | 2014-10-30 | $33.52 million | $0.03 | $0.02 | 50% |
| 2014-06-30 | 2014-07-28 | $25.57 million | $-0.00 | ||
| 2014-03-31 | 2014-04-25 | $19.56 million | -$0.01 | -$0.02 | 50% |
| 2013-12-31 | 2014-02-26 | $17.99 million | -$0.01 | -$0.01 | 0% |
| 2013-09-30 | 2013-10-30 | $16.12 million | $-0.00 | ||
| 2013-06-30 | 2013-07-31 | $13.52 million | -$0.01 | -$0.01 | 0% |
| 2013-03-31 | 2013-05-01 | $11.56 million | -$0.02 | -$0.01 | -100% |
| 2012-12-31 | 2013-03-07 | $10.51 million | -$0.02 | -$0.01 | -100% |
| 2012-09-30 | 2012-11-28 | $7.95 million | -$0.05 | ||
| 2012-06-30 | 2012-08-29 | $4.88 million | -$0.01 | ||
| 2012-03-31 | 2012-05-30 | $3.71 million | -$0.01 | ||
| 2011-12-31 | 2011-12-31 | $2.64 million | -$0.04 | ||
| 2011-09-30 | 2011-09-30 | $2.15 million | -$0.02 | ||
| 2011-06-30 | 2011-06-30 | $1.93 million | -$0.03 | ||
| 2011-03-31 | 2011-03-31 | $1.04 million | -$0.05 | ||
| 2010-12-31 | 2010-12-31 | -$0.05 | |||
| 2010-09-30 | 2010-09-30 | -$0.05 | |||
| 2010-06-30 | 2010-06-30 | -$0.04 | |||
| 2010-03-31 | 2010-03-31 | -$0.06 | |||
| 2008-12-31 | 2008-12-31 | -$0.08 | |||
| 2008-09-30 | 2008-09-30 | -$0.13 | |||
| 2008-06-30 | 2008-06-30 | -$0.09 |
MiMedx Group, Inc (MDXG) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
MiMedx Group, Inc (MDXG) Chart:
MiMedx Group, Inc (MDXG) News:
Below you will find a list of latest news for MiMedx Group, Inc (MDXG) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
MiMedx Group, Inc (MDXG) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2.5 | 0 | CALL | 0 | 0 | 390.12 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 1.4 | CALL | 10 | 5 | 104.42 | TRUE | 1.4 | 0 |
| 2024-05-17 | 7.5 | 0.05 | CALL | 1 | 114 | 86.39 | FALSE | 0.05 | 0 |
| 2024-05-17 | 10 | 0.06 | CALL | 0 | 22 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 12.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 15 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 5 | 0.2 | PUT | 138 | 40 | 120.51 | FALSE | 0.2 | 0 |
| 2024-05-17 | 7.5 | 1.55 | PUT | 3595 | 20 | 119.64 | TRUE | 1.55 | 0 |
| 2024-05-17 | 10 | 0 | PUT | 0 | 0 | 258.6 | TRUE | 0 | 0 |
| 2024-05-17 | 12.5 | 0 | PUT | 0 | 0 | 251.34 | TRUE | 0 | 0 |
| 2024-05-17 | 15 | 0 | PUT | 0 | 0 | 423.24 | TRUE | 0 | 0 |
| 2024-06-21 | 2.5 | 3.4 | CALL | 2 | 1 | 220.82 | TRUE | 3.4 | 0 |
| 2024-06-21 | 5 | 1.54 | CALL | 0 | 116 | 259.95 | TRUE | 0 | 0 |
| 2024-06-21 | 7.5 | 0.19 | CALL | 0 | 1131 | 73.45 | FALSE | 0 | 0 |
| 2024-06-21 | 10 | 0.05 | CALL | 0 | 786 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 12.5 | 0.05 | CALL | 0 | 74 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 15 | 0.1 | CALL | 0 | 8 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 5 | 0.11 | PUT | 0 | 145 | 78.68 | FALSE | 0 | 0 |
| 2024-06-21 | 7.5 | 1.8 | PUT | 475 | 514 | 103.21 | TRUE | 1.8 | 0 |
| 2024-06-21 | 10 | 2.13 | PUT | 0 | 5 | 173.2 | TRUE | 0 | 0 |
| 2024-06-21 | 12.5 | 0 | PUT | 0 | 0 | 242.16 | TRUE | 0 | 0 |
| 2024-06-21 | 15 | 0 | PUT | 0 | 0 | 177.4 | TRUE | 0 | 0 |
| 2024-09-20 | 2.5 | 0 | CALL | 0 | 0 | 107.94 | TRUE | 0 | 0 |
| 2024-09-20 | 5 | 1.3 | CALL | 2 | 3 | 97.14 | TRUE | 1.3 | 0 |
| 2024-09-20 | 7.5 | 0.5 | CALL | 0 | 266 | 58.81 | FALSE | 0 | 0 |
| 2024-09-20 | 10 | 0.42 | CALL | 0 | 69 | 77.88 | FALSE | 0 | 0 |
| 2024-09-20 | 12.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 15 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 5 | 0.35 | PUT | 0 | 245 | 74.37 | FALSE | 0 | 0 |
| 2024-09-20 | 7.5 | 1.45 | PUT | 0 | 222 | 58.98 | TRUE | 0 | 0 |
| 2024-09-20 | 10 | 2.5 | PUT | 0 | 51 | 65.15 | TRUE | 0 | 0 |
| 2024-09-20 | 12.5 | 0 | PUT | 0 | 0 | 159.13 | TRUE | 0 | 0 |
| 2024-09-20 | 15 | 0 | PUT | 0 | 0 | 170.99 | TRUE | 0 | 0 |
| 2024-12-20 | 2.5 | 0 | CALL | 0 | 0 | 162.55 | TRUE | 0 | 0 |
| 2024-12-20 | 5 | 0 | CALL | 0 | 0 | 62.61 | TRUE | 0 | 0 |
| 2024-12-20 | 7.5 | 0 | CALL | 0 | 0 | 53.7 | FALSE | 0 | 0 |
| 2024-12-20 | 10 | 0 | CALL | 0 | 0 | 52.05 | FALSE | 0 | 0 |
| 2024-12-20 | 12.5 | 0 | CALL | 0 | 0 | 58.57 | FALSE | 0 | 0 |
| 2024-12-20 | 2.5 | 0.1 | PUT | 70 | 0 | 85.45 | FALSE | 0.1 | 0 |
| 2024-12-20 | 5 | 0.45 | PUT | 0 | 10 | 59.88 | FALSE | 0 | 0 |
| 2024-12-20 | 7.5 | 1.58 | PUT | 0 | 10 | 52.73 | TRUE | 0 | 0 |
| 2024-12-20 | 10 | 3.7 | PUT | 0 | 150 | 96.9 | TRUE | 0 | 0 |
| 2024-12-20 | 12.5 | 0 | PUT | 0 | 0 | 119.29 | TRUE | 0 | 0 |
Latest MDXG Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 300 | $3.175 |
| Jun 13, 2022 7:59 PM EST | 100 | $3.175 |
| Jun 13, 2022 7:59 PM EST | 100 | $3.175 |
| Jun 13, 2022 7:59 PM EST | 400 | $3.175 |
| Jun 13, 2022 7:59 PM EST | 2 | $3.17 |
MiMedx Group, Inc (MDXG) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000035/0001376339-20-000035-index.htm |
| 2020-07-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000089924320019006/0000899243-20-019006-index.htm |
| 2019-06-14 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1376339/000090266419002778/0000902664-19-002778-index.htm |
| 2019-06-17 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1376339/000090266419002784/0000902664-19-002784-index.htm |
| 2019-06-17 | DFAN14A | Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1376339/000090266419002785/0000902664-19-002785-index.htm |
| 2020-07-14 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1376339/000101143820000168/0001011438-20-000168-index.htm |
| 2020-07-15 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1376339/000101143820000171/0001011438-20-000171-index.htm |
| 2020-07-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000101783220000002/0001017832-20-000002-index.htm |
| 2020-08-28 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000101783220000004/0001017832-20-000004-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1376339/000101905620000163/0001019056-20-000163-index.htm |
| 2019-06-13 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1376339/000119312519172511/0001193125-19-172511-index.htm |
| 2019-06-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000119312519173104/0001193125-19-173104-index.htm |
| 2019-06-14 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1376339/000119312519173699/0001193125-19-173699-index.htm |
| 2019-06-14 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1376339/000119312519173708/0001193125-19-173708-index.htm |
| 2019-06-14 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1376339/000119312519173715/0001193125-19-173715-index.htm |
| 2019-06-17 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1376339/000119312519174775/0001193125-19-174775-index.htm |
| 2019-06-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000119312519176584/0001193125-19-176584-index.htm |
| 2019-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000119312519213015/0001193125-19-213015-index.htm |
| 2019-08-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000119312519217216/0001193125-19-217216-index.htm |
| 2019-08-09 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB | https://www.sec.gov/Archives/edgar/data/1376339/000119312519218035/0001193125-19-218035-index.htm |
| 2020-07-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000119312520187301/0001193125-20-187301-index.htm |
| 2020-07-13 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1376339/000119312520191931/0001193125-20-191931-index.htm |
| 2020-07-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000119312520193404/0001193125-20-193404-index.htm |
| 2020-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000119312520214251/0001193125-20-214251-index.htm |
| 2020-08-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000119312520235594/0001193125-20-235594-index.htm |
| 2020-09-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000119312520248152/0001193125-20-248152-index.htm |
| 2020-09-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000119312520249566/0001193125-20-249566-index.htm |
| 2020-09-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000119312520250221/0001193125-20-250221-index.htm |
| 2020-08-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000128824520000002/0001288245-20-000002-index.htm |
| 2020-11-03 | CERT | Certification | https://www.sec.gov/Archives/edgar/data/1376339/000135445720000665/0001354457-20-000665-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633919000025/0001376339-19-000025-index.htm |
| 2019-06-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633919000027/0001376339-19-000027-index.htm |
| 2019-06-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633919000028/0001376339-19-000028-index.htm |
| 2019-06-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633919000029/0001376339-19-000029-index.htm |
| 2019-06-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633919000030/0001376339-19-000030-index.htm |
| 2019-07-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633919000032/0001376339-19-000032-index.htm |
| 2019-08-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000137633919000034/0001376339-19-000034-index.htm |
| 2019-09-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000137633919000036/0001376339-19-000036-index.htm |
| 2019-09-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000137633919000038/0001376339-19-000038-index.htm |
| 2019-10-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633919000039/0001376339-19-000039-index.htm |
| 2019-11-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633919000041/0001376339-19-000041-index.htm |
| 2019-11-12 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB | https://www.sec.gov/Archives/edgar/data/1376339/000137633919000043/0001376339-19-000043-index.htm |
| 2019-11-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000137633919000048/0001376339-19-000048-index.htm |
| 2019-12-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000137633919000050/0001376339-19-000050-index.htm |
| 2020-01-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000002/0001376339-20-000002-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000004/0001376339-20-000004-index.htm |
| 2020-03-17 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000009/0001376339-20-000009-index.htm |
| 2020-03-18 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000010/0001376339-20-000010-index.htm |
| 2020-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000011/0001376339-20-000011-index.htm |
| 2020-03-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000013/0001376339-20-000013-index.htm |
| 2020-04-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000015/0001376339-20-000015-index.htm |
| 2020-04-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000017/0001376339-20-000017-index.htm |
| 2020-04-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000019/0001376339-20-000019-index.htm |
| 2020-04-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000023/0001376339-20-000023-index.htm |
| 2020-04-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000024/0001376339-20-000024-index.htm |
| 2020-04-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000025/0001376339-20-000025-index.htm |
| 2020-05-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000027/0001376339-20-000027-index.htm |
| 2020-05-11 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000030/0001376339-20-000030-index.htm |
| 2020-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000031/0001376339-20-000031-index.htm |
| 2020-05-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000033/0001376339-20-000033-index.htm |
| 2020-06-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000035/0001376339-20-000035-index.htm |
| 2020-07-06 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000045/0001376339-20-000045-index.htm |
| 2020-07-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000047/0001376339-20-000047-index.htm |
| 2020-07-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000051/0001376339-20-000051-index.htm |
| 2020-07-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000052/0001376339-20-000052-index.htm |
| 2020-07-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000053/0001376339-20-000053-index.htm |
| 2020-07-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000055/0001376339-20-000055-index.htm |
| 2020-07-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000058/0001376339-20-000058-index.htm |
| 2020-07-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000060/0001376339-20-000060-index.htm |
| 2020-07-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000062/0001376339-20-000062-index.htm |
| 2020-08-03 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000066/0001376339-20-000066-index.htm |
| 2020-08-03 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000067/0001376339-20-000067-index.htm |
| 2020-08-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000069/0001376339-20-000069-index.htm |
| 2020-08-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000072/0001376339-20-000072-index.htm |
| 2020-08-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000073/0001376339-20-000073-index.htm |
| 2020-08-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000084/0001376339-20-000084-index.htm |
| 2020-08-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000085/0001376339-20-000085-index.htm |
| 2020-08-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000086/0001376339-20-000086-index.htm |
| 2020-08-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000087/0001376339-20-000087-index.htm |
| 2020-08-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000088/0001376339-20-000088-index.htm |
| 2020-08-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000089/0001376339-20-000089-index.htm |
| 2020-08-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000090/0001376339-20-000090-index.htm |
| 2020-08-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000091/0001376339-20-000091-index.htm |
| 2020-08-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000093/0001376339-20-000093-index.htm |
| 2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000095/0001376339-20-000095-index.htm |
| 2020-08-28 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000097/0001376339-20-000097-index.htm |
| 2020-08-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000099/0001376339-20-000099-index.htm |
| 2020-09-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000105/0001376339-20-000105-index.htm |
| 2020-09-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000107/0001376339-20-000107-index.htm |
| 2020-10-05 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000112/0001376339-20-000112-index.htm |
| 2020-10-05 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000122/0001376339-20-000122-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000123/0001376339-20-000123-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000124/0001376339-20-000124-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000125/0001376339-20-000125-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000126/0001376339-20-000126-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000127/0001376339-20-000127-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000128/0001376339-20-000128-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000129/0001376339-20-000129-index.htm |
| 2020-10-15 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000132/0001376339-20-000132-index.htm |
| 2020-10-15 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000134/0001376339-20-000134-index.htm |
| 2020-10-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000137/0001376339-20-000137-index.htm |
| 2020-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000139/0001376339-20-000139-index.htm |
| 2020-10-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000142/0001376339-20-000142-index.htm |
| 2020-11-02 | 8-A12B | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000144/0001376339-20-000144-index.htm |
| 2020-11-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000147/0001376339-20-000147-index.htm |
| 2020-11-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000148/0001376339-20-000148-index.htm |
| 2019-12-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137932019000004/0001379320-19-000004-index.htm |
| 2019-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137932019000006/0001379320-19-000006-index.htm |
| 2020-07-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137932020000002/0001379320-20-000002-index.htm |
| 2020-08-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137932020000004/0001379320-20-000004-index.htm |
| 2020-11-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000137932020000006/0001379320-20-000006-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000143565520000002/0001435655-20-000002-index.htm |
| 2020-08-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000176179620000002/0001761796-20-000002-index.htm |
| 2019-12-09 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000179604419000002/0001796044-19-000002-index.htm |
| 2020-08-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000179604420000002/0001796044-20-000002-index.htm |
| 2020-02-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000180389320000002/0001803893-20-000002-index.htm |
| 2020-08-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000180389320000004/0001803893-20-000004-index.htm |
| 2020-08-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000181181420000002/0001811814-20-000002-index.htm |
| 2020-11-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1376339/000181181420000004/0001811814-20-000004-index.htm |
MiMedx Group, Inc (MDXG) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of MiMedx Group, Inc (MDXG). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 637%Institutional Ownership: 1210%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-08-05 | NEIL YESTON | Director | Buy | 29,661.00 | 100,121.00 | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000084/0001376339-20-000084-index.htm | ||
| 2020-08-05 | TIMOTHY R WRIGHT | Chief Executive Officer | Buy | 572,033.00 | 1,164,260.00 | https://www.sec.gov/Archives/edgar/data/1376339/000128824520000002/0001288245-20-000002-index.htm | ||
| 2020-08-05 | William Frank IV Hulse | General Counsel | Buy | 120,762.00 | 120,762.00 | https://www.sec.gov/Archives/edgar/data/1376339/000179604420000002/0001796044-20-000002-index.htm | ||
| 2020-10-02 | Charles Robert Evans | Director | Buy | 26,236.00 | 6.67 | 174,994.12 | 121,357.00 | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000125/0001376339-20-000125-index.htm |
| 2020-10-02 | NEIL YESTON | Director | Buy | 26,236.00 | 6.67 | 174,994.12 | 126,357.00 | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000129/0001376339-20-000129-index.htm |
| 2020-10-02 | CHARLES E KOOB | Director | Buy | 26,236.00 | 6.67 | 174,994.12 | 1,431,525.00 | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000127/0001376339-20-000127-index.htm |
| 2020-01-22 | CHARLES E KOOB | Director | Buy | 15,000.00 | 1.20 | 18,000.00 | 15,000.00 | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000002/0001376339-20-000002-index.htm |
| 2020-08-05 | CHARLES E KOOB | Director | Buy | 29,661.00 | 1,505,289.00 | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000089/0001376339-20-000089-index.htm | ||
| 2020-08-05 | Scott M Turner | SVP, Operations & Procurement | Buy | 48,135.00 | 152,978.00 | https://www.sec.gov/Archives/edgar/data/1376339/000176179620000002/0001761796-20-000002-index.htm | ||
| 2020-08-05 | J TERRY DEWBERRY | Director | Buy | 29,661.00 | 156,787.00 | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000091/0001376339-20-000091-index.htm | ||
| 2020-08-03 | Rohit Kashyap | EVP & Chief Commercial Officer | Buy | 173,310.00 | 5.77 | 999,998.70 | 173,310.00 | https://www.sec.gov/Archives/edgar/data/1376339/000143565520000002/0001435655-20-000002-index.htm |
| 2019-06-20 | JOSEPH G BLESER | Director | Buy | 50,000.00 | 0.70 | 35,000.00 | 181,545.00 | https://www.sec.gov/Archives/edgar/data/1376339/000137633919000025/0001376339-19-000025-index.htm |
| 2020-08-05 | Peter M Carlson | Chief Financial Officer | Buy | 177,966.00 | 262,472.00 | https://www.sec.gov/Archives/edgar/data/1376339/000137932020000004/0001379320-20-000004-index.htm | ||
| 2020-11-04 | Peter M Carlson | Chief Financial Officer | Buy | 35,211.00 | 7.23 | 254,575.53 | 297,683.00 | https://www.sec.gov/Archives/edgar/data/1376339/000137932020000006/0001379320-20-000006-index.htm |
| 2020-08-05 | Richard Barry | Director | Buy | 38,135.00 | 3,338,135.00 | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000088/0001376339-20-000088-index.htm | ||
| 2020-08-05 | JAMES L BIERMAN | Director | Buy | 38,135.00 | 38,135.00 | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000085/0001376339-20-000085-index.htm | ||
| 2020-08-05 | M KATHLEEN BEHRENS | Director | Buy | 38,135.00 | 38,135.00 | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000086/0001376339-20-000086-index.htm | ||
| 2020-08-05 | Todd Newton | Director | Buy | 38,135.00 | 38,135.00 | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000090/0001376339-20-000090-index.htm | ||
| 2020-10-02 | WILLIAM A HAWKINS | Director | Buy | 26,236.00 | 6.67 | 174,994.12 | 39,654.00 | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000126/0001376339-20-000126-index.htm |
| 2019-12-16 | Peter M Carlson | EVP, Finance | Buy | 49,295.00 | 7.10 | 349,994.50 | 49,295.00 | https://www.sec.gov/Archives/edgar/data/1376339/000137932019000006/0001379320-19-000006-index.htm |
| 2020-08-05 | William Lawrence Phelan | Chief Accounting Officer | Buy | 59,322.00 | 59,322.00 | https://www.sec.gov/Archives/edgar/data/1376339/000181181420000002/0001811814-20-000002-index.htm | ||
| 2020-10-02 | JAMES L BIERMAN | Director | Buy | 26,236.00 | 6.67 | 174,994.12 | 64,371.00 | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000124/0001376339-20-000124-index.htm |
| 2020-10-02 | M KATHLEEN BEHRENS | Director | Buy | 26,236.00 | 6.67 | 174,994.12 | 64,371.00 | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000123/0001376339-20-000123-index.htm |
| 2020-10-02 | Todd Newton | Director | Buy | 26,236.00 | 6.67 | 174,994.12 | 64,371.00 | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000128/0001376339-20-000128-index.htm |
| 2020-11-04 | William Lawrence Phelan | Chief Accounting Officer | Buy | 8,474.00 | 7.23 | 61,267.02 | 67,796.00 | https://www.sec.gov/Archives/edgar/data/1376339/000181181420000004/0001811814-20-000004-index.htm |
| 2020-08-05 | Mark Graves | SVP & Chief Compliance Officer | Buy | 35,254.00 | 79,989.00 | https://www.sec.gov/Archives/edgar/data/1376339/000180389320000004/0001803893-20-000004-index.htm | ||
| 2020-08-10 | Robert Benjamin Stein | EVP, Research and Development | Buy | 81,833.00 | 6.11 | 499,999.63 | 81,833.00 | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000095/0001376339-20-000095-index.htm |
| 2020-07-06 | Peter M Carlson | Chief Financial Officer | Buy | 35,211.00 | 5.40 | 190,139.40 | 84,506.00 | https://www.sec.gov/Archives/edgar/data/1376339/000137932020000002/0001379320-20-000002-index.htm |
| 2020-08-05 | Charles Robert Evans | Director | Buy | 29,661.00 | 95,121.00 | https://www.sec.gov/Archives/edgar/data/1376339/000137633920000087/0001376339-20-000087-index.htm |